Insider Transactions in Q1 2024 at National Healthcare Corp (NHC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,257
-2.07%
|
$312,672
$96.48 P/Share
|
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+2.78%
|
$238,500
$53.94 P/Share
|
|
Mar 12
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-20.59%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+22.68%
|
$197,849
$53.94 P/Share
|
|
Mar 12
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,807
-10.57%
|
$269,472
$96.48 P/Share
|
|
Mar 12
2024
|
Brian F Kidd SVP, Controller, PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+13.09%
|
$212,000
$53.94 P/Share
|
|
Mar 12
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,810
-2.92%
|
$173,760
$96.48 P/Share
|
|
Mar 12
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.87%
|
$132,500
$53.94 P/Share
|
|
Mar 12
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-17.81%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+20.24%
|
$197,849
$53.94 P/Share
|
|
Mar 12
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-27.35%
|
$251,520
$96.48 P/Share
|
|
Mar 12
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+28.04%
|
$197,849
$53.94 P/Share
|
|
Mar 05
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
1,239
+10.14%
|
-
|
|
Mar 05
2024
|
Brian F Kidd SVP, Controller, PAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+5.88%
|
-
|
|
Mar 05
2024
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,563
+1.65%
|
-
|
|
Mar 05
2024
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+4.47%
|
-
|
|
Mar 05
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+19.97%
|
-
|
|
Mar 05
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
1,018
+14.83%
|
-
|
|
Mar 05
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+10.66%
|
-
|
|
Feb 29
2024
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,911
-41.32%
|
$285,278
$98.66 P/Share
|
|
Feb 29
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+34.64%
|
$235,179
$63.96 P/Share
|
|
Feb 27
2024
|
Ernest G Burgess Iii Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,000
+2.3%
|
$128,000
$64.64 P/Share
|
|
Feb 22
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-22.4%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+22.93%
|
$235,179
$63.96 P/Share
|
|
Feb 22
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-26.2%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+25.81%
|
$235,179
$63.96 P/Share
|
|
Feb 22
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,651
-6.04%
|
$365,100
$100.76 P/Share
|
|
Feb 22
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,733
+7.27%
|
$298,179
$63.96 P/Share
|
|
Feb 22
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-36.79%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+32.82%
|
$235,179
$63.96 P/Share
|
|
Feb 22
2024
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,245
-2.11%
|
$324,500
$100.76 P/Share
|
|
Feb 22
2024
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,233
+2.68%
|
$266,679
$63.96 P/Share
|
|
Feb 22
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-11.73%
|
$281,100
$100.76 P/Share
|
|
Feb 22
2024
|
Brian F Kidd SVP, Controller, PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,733
+13.48%
|
$235,179
$63.96 P/Share
|
|
Feb 16
2024
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,745
+4.76%
|
$123,895
$71.64 P/Share
|
|
Jan 04
2024
|
James Paul Abernathy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,185
-13.53%
|
$482,205
$93.5 P/Share
|
|
Jan 04
2024
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,395
+15.26%
|
$951,045
$71.28 P/Share
|
|
Jan 04
2024
|
James Paul Abernathy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,912
-13.75%
|
$456,816
$93.5 P/Share
|
|
Jan 01
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-4.77%
|
$31,464
$92.42 P/Share
|
|
Jan 01
2024
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-6.8%
|
$26,220
$92.42 P/Share
|
|
Jan 01
2024
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-0.62%
|
$66,816
$72.42 P/Share
|
|
Jan 01
2024
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-5.04%
|
$41,032
$92.42 P/Share
|
|
Jan 01
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-1.76%
|
$91,816
$92.42 P/Share
|
|
Jan 01
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-2.01%
|
$37,996
$92.42 P/Share
|
|
Jan 01
2024
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-11.02%
|
$37,720
$92.42 P/Share
|